Inventor · disambiguated record
Steven R. Magnuson
Also filed as: MAGNUSON STEVEN · MAGNUSON STEVEN R
44 granted patents·25 pending applications·270 citations·filing 2000–2023
97Inventor score
Top patents by PatentIndex Score
69 records- 0193US6787651B2Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-γ binding agentsSMITHKLINE BEECHAM CORP·Filed 2001·Granted Sep 7, 2004·72 cites·14 claims
- 0292US9763922B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2015·Granted Sep 19, 2017·9 cites·20 claims
- 0388US8486950B2Janus kinase inhibitor compounds and methodsGOODACRE SIMON CHARLES·Filed 2010·Granted Jul 16, 2013·25 cites·19 claims
- 0488US7563791B2Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisBAYER PHARMACEUTICALS CORP·Filed 2005·Granted Jul 21, 2009·14 cites·8 claims
- 0587US10308614B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Granted Jun 4, 2019·4 cites·21 claims
- 0687US8999998B2Pyrazolopyrimidine JAK inhibitor compounds and methodsGIBBONS PAUL·Filed 2010·Granted Apr 7, 2015·7 cites·1 claims
- 0787US8637526B2Pyrazolopyrimidine JAK inhibitor compounds and methodsBLANEY JEFFREY·Filed 2011·Granted Jan 28, 2014·17 cites·18 claims
- 0886US6660752B22,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonistsBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Dec 9, 2003·24 cites·30 claims
- 0985US6900205B21,8-Naphthyridine derivatives and their use to treat diabetes and related disordersBAYER PHARMACEUTICALS CORP·Filed 2002·Granted May 31, 2005·19 cites·36 claims
- 1085US2024150364A1Pyrazolopyrimidine jak inhibitor compounds and methodsGENENTECH INC·Filed 2023·Application pending·0 cites
- 1183US11247989B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2018·Granted Feb 15, 2022·2 cites·8 claims
- 1283US10206931B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Granted Feb 19, 2019·5 cites·17 claims
- 1382US8609687B2Triazolopyridine JAK inhibitor compounds and methodsZHU BING-YAN·Filed 2012·Granted Dec 17, 2013·7 cites·45 claims
- 1481US9309240B2Pyrazolopyridine compounds, compositions and methods of useHOFFMANN LA ROCHE·Filed 2013·Granted Apr 12, 2016·6 cites·16 claims
- 1580US9382241B2Aminoquinazoline and pyridopyrimidine derivativesGENENTECH INC·Filed 2013·Granted Jul 5, 2016·2 cites·25 claims
- 1680US7517878B2Heteroarylaminopyrazole derivatives useful for the treatment of diabetesBAYER PHARAMCEUTICALS CORP·Filed 2005·Granted Apr 14, 2009·8 cites·9 claims
- 1779US10183009B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Granted Jan 22, 2019·3 cites·22 claims
- 1879US9505767B2Pyrazolo[1,5-A]pyrimidin-7(4H)-onehistone demethylase inhibitorsGENENTECH INC·Filed 2014·Granted Nov 29, 2016·4 cites·3 claims
- 1979US8143393B2Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisDIXON JULIE A·Filed 2006·Granted Mar 27, 2012·5 cites·11 claims
- 2078US8129379B2Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisDIXON JULIE A·Filed 2009·Granted Mar 6, 2012·4 cites·2 claims
- 2177US2022389020A1Pyrazolopyrimidine jak inhibitor compounds and methodsGENENTECH INC·Filed 2022·Application pending·0 cites
- 2276US10696655B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2018·Granted Jun 30, 2020·1 cites·20 claims
- 2376US7109196B21,8 Naphthyridine derivatives and their use to treat diabetes and related disordersBAYER PHARMACEUTICALS CORP·Filed 2004·Granted Sep 19, 2006·7 cites·20 claims
- 2474US8697708B2Azabenzothiazole compounds, compositions and methods of useBLENCH TOBY JONATHAN·Filed 2011·Granted Apr 15, 2014·3 cites·1 claims
- 2572US8133995B2Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisDIXON JULIE·Filed 2006·Granted Mar 13, 2012·4 cites·13 claims
- 2672US6699860B2Di-substituted aminomethyl-chroman derivative beta-3 adrenoreceptor agonistsBAYER PHARMACEUTICALS CORP·Filed 2001·Granted Mar 2, 2004·8 cites·20 claims
- 2771US8829185B2Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisDIXON JULIE A·Filed 2012·Granted Sep 9, 2014·2 cites·5 claims
- 2871US2020002345A1Pyrazolopyrimidine jak inhibitor compounds and methodsGENENTECH INC·Filed 2019·Application pending·0 cites
- 2969US9434732B2Triazolopyridine JAK inhibitor compounds and methodsGENENTECH INC·Filed 2013·Granted Sep 6, 2016·1 cites·46 claims
- 3069US8138336B2Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinaseMAGNUSON STEVEN·Filed 2008·Granted Mar 20, 2012·2 cites·15 claims
- 3168US10150767B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Granted Dec 11, 2018·1 cites·14 claims
- 3266US6919371B22,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonistsBAYER PHARMACEUTICALS CORP·Filed 2003·Granted Jul 19, 2005·2 cites·24 claims
- 3364US2022127265A1Therapeutic compounds and uses thereofGENENTECH INC·Filed 2022·Application pending·0 cites
- 3464US2017283424A1Pyrazolopyrimidine jak inhibitor compounds and methodsGENENTECH INC·Filed 2017·Application pending·0 cites
- 3563US7265144B2Anilinopyrazole derivatives useful for the treatment of diabetesBAYER PHARMACEUTICALS CORP·Filed 2003·Granted Sep 4, 2007·2 cites·40 claims
- 3662US8338595B2Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisDIXON JULIE A·Filed 2009·Granted Dec 25, 2012·0 cites·8 claims
- 3762US2010048557A1Triazolopyridine JAK Inhibitor Compounds and MethodsZHU BING-YAN·Filed 2009·Application pending·0 cites
- 3862US2010035875A1Triazolopyridine jak inhibitor compounds and methodsZHU BING-YAN·Filed 2009·Application pending·0 cites
- 3961US11168070B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2020·Granted Nov 9, 2021·0 cites·14 claims
- 4059US2006189609A11, 8-Naphthyridine derivatives and their use to treat diabetes and related disordersBAYER PHARMACEUTICALS CORP·Filed 2006·Application pending·0 cites
- 4159US2009209451A1Heteroarylaminopyrazole derivatives useful for the treatment of diabetesBAYER PHARMACEUTICALS CORP·Filed 2009·Application pending·0 cites
- 4258US2014378449A1Triazolopyridine jak inhibitor compounds and methodsGENENTECH INC·Filed 2014·Application pending·0 cites
- 4357US2024425478A1Cyclopentylpyrazole cdk2 inhibitorsGENENTECH INC·Filed 2022·Application pending·0 cites
- 4457US2014107099A1Pyrazolopyrimidine jak inhibitor compounds and methodsGENENTECH INC·Filed 2013·Application pending·0 cites
- 4556US9592235B2Aminoquinazoline and pyridopyrimidine derivativesGENENTECH INC·Filed 2016·Granted Mar 14, 2017·0 cites·2 claims
- 4656US8889673B2Triazolopyridine JAK inhibitor compounds and methodsZHU BING-YAN·Filed 2012·Granted Nov 18, 2014·0 cites·6 claims
- 4755US9855269B2Aminoquinazoline and pyridopyrimidine derivativesGENENTECH INC·Filed 2017·Granted Jan 2, 2018·0 cites·2 claims
- 4855US2017333406A1Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Application pending·0 cites
- 4954US2015152117A1Pyrazolopyrimidine jak inhibitor compounds and methodsGENENTECH INC·Filed 2015·Application pending·0 cites
- 5053US2013225809A1Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisBAYER HEALTHCARE LLC·Filed 2012·Application pending·0 cites
Showing the top 50 of 69 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Steven R. Magnuson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →